Evidence map›Paper›PMID 40321654›Full record

ArticleLancet regional health. Americas2025

Associations of

Christian S Alvarez, Robert C Kaplan, M Constanza Camargo, M Larissa Avilés-Santa, Martha Daviglus, Olga Garcia-Bedoya, Carmen R Isasi, Maria S Pattany, Bharat Thyagarajan, Gregory A Talavera and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Relationship betweenWorld journal of gastroenterology · 2025
    Article
  2. Article
  3. Improving outcomes in MASLD: the role ofLancet regional health. Americas · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christian S AlvarezDivision of Intramural Research, National Institute on Minority Health and Health Disparities, NIH, Rockville, MD, USA.
Robert C KaplanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
M Larissa Avilés-SantaDivision of Clinical and Health Services Research, National Institute on Minority Health and Health Disparities, Rockville, MD, USA.
Martha DaviglusInstitute for Minority Health Research, University of Illinois Chicago, Chicago, IL, USA.
Olga Garcia-BedoyaInstitute for Minority Health Research, University of Illinois Chicago, Chicago, IL, USA.
Carmen R IsasiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Maria S PattanyDepartment of Psychology, College of Arts and Sciences, University of Miami, Coral Gables, Florida.
Bharat ThyagarajanDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Gregory A TalaveraSouth Bay Latino Research Center, Department of Psychology, San Diego State University, San Diego, CA, USA.
Barry I GraubardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Katherine A McGlynnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hispanic/Latino populations have been reported to have high rates of both metabolic dysfunction-associated steatotic liver disease (MASLD) and Methods: In this cross-sectional study, a total of 16,144 participants with baseline data on Findings: The overall prevalence of MASLD ranged from 47% (FLI) to 65% (HSI). After accounting for age, sex, education, and other key variables, the analysis found a modest association between Interpretation: This study provides support for a positive association of Funding: The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), San Diego State University (N01-HC65237), and University of Illinois at Chicago (HHSN268201300003I). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, United States, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. This study was also funded in part by the Intramural Research Program of the National Cancer Institute.

Indexed as

Helicobacter pyloriHispanic/LatinoMASLD

Identifiers

PMID40321654
PMCPMC12049732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.